A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia
Phase of Trial: Phase IV
Latest Information Update: 17 Feb 2017
At a glance
- Drugs Kanglaite (Primary)
- Indications Cachexia
- Focus Therapeutic Use
- Sponsors Zhejiang Kanglaite Pharmaceutical
- 14 Feb 2017 Planned End Date changed from 1 Apr 2017 to 1 Jul 2018.
- 14 Feb 2017 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2017.
- 22 Sep 2015 New trial record